Ricard Mesı́a
Universitat Autònoma de Barcelona(ES)Institut Català d'Ornitologia(ES)Institut Català d'Oncologia(ES)Badalona Serveis Assistencials(ES)Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol(ES)Hospital Municipal de Badalona(ES)Hospital Universitari Germans Trias i Pujol(ES)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Cancer Diagnosis and Treatment, Head and Neck Surgical Oncology
Most-Cited Works
- → Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer(2008)3,682 cited
- → Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study(2019)3,087 cited
- → Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer(2007)1,699 cited
- → The Multidisciplinary Team (MDT) Approach and Quality of Care(2020)464 cited
- → Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study(2022)450 cited
- → Human papillomavirus-related oropharyngeal cancer(2017)395 cited